Comment by
Vinnyboombatz on Oct 20, 2017 10:39am
This post has been removed in accordance with Community Policy
Comment by
PCR1917 on Oct 20, 2017 11:55am
Someone here mentioned Apotex, which i think is more probable than shoppers since the latter is publicly traded. The other thing is that i doubt shoppers would like to own a drug producer, it would not fit their company's model.
Comment by
altitudes on Oct 20, 2017 11:57am
its definitely not shoppers. If anything they will buy directly from APH.
Comment by
PCR1917 on Oct 20, 2017 12:06pm
I don't think they would buy directly from Aphria. I think they would by PPP001, and this would have to be from our partnership.
Comment by
PCR1917 on Oct 20, 2017 12:15pm
More than that, from the moment there is a DIN for cannabis, I think it won't make any sense for any pharmacy to sell any other "medicinal" marijuana. I would even say that it won't make sense anymore for any patient to buy any other "medicinal" pot from any other licenced producer. This DIN would really be a game changer and that is why I'm invested here.
Comment by
Vinnyboombatz on Oct 20, 2017 12:13pm
This post has been removed in accordance with Community Policy
Comment by
PCR1917 on Oct 20, 2017 12:18pm
Exactly, shoppers wants to sell. They don't want to be the producer and I don't think they want to buy it neither.
Comment by
Mellodraw on Oct 20, 2017 12:26pm
On that note, does anyone think some of this recent drop might be due to confusion between the PPP001 partnership for DIN sales and the partnership with aph for non-DIN sales?
Comment by
LeafRider on Oct 20, 2017 2:56pm
This post has been removed in accordance with Community Policy
Comment by
altitudes on Oct 20, 2017 3:42pm
on that note some investors are probably on the sidelines until a capital raise happens.